AR002194A1 - Instrumento computarizado para el analisis del movimiento. - Google Patents

Instrumento computarizado para el analisis del movimiento.

Info

Publication number
AR002194A1
AR002194A1 ARP960102868A AR10286896A AR002194A1 AR 002194 A1 AR002194 A1 AR 002194A1 AR P960102868 A ARP960102868 A AR P960102868A AR 10286896 A AR10286896 A AR 10286896A AR 002194 A1 AR002194 A1 AR 002194A1
Authority
AR
Argentina
Prior art keywords
movement
computer
tabletop
analysis
equipment
Prior art date
Application number
ARP960102868A
Other languages
English (en)
Spanish (es)
Inventor
Sanchez Reynaldo Alemany
Espinosa Roberto Hernandez
Guillermo Digiacinti
Guillermo Moricon
Original Assignee
Sanchez Reynaldo Alemany
Espinosa Roberto Hernandez
Guillermo Digiacinti
Guillermo Moricon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38729083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR002194(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanchez Reynaldo Alemany, Espinosa Roberto Hernandez, Guillermo Digiacinti, Guillermo Moricon filed Critical Sanchez Reynaldo Alemany
Publication of AR002194A1 publication Critical patent/AR002194A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP960102868A 1997-03-17 1996-06-03 Instrumento computarizado para el analisis del movimiento. AR002194A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81922197A 1997-03-17 1997-03-17

Publications (1)

Publication Number Publication Date
AR002194A1 true AR002194A1 (es) 1998-01-07

Family

ID=38729083

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP960102868A AR002194A1 (es) 1997-03-17 1996-06-03 Instrumento computarizado para el analisis del movimiento.
ARP980101150A AR011192A1 (es) 1997-03-17 1998-03-13 Composiciones oftalmicas que comprenden una prostaglandina y el uso de los mismos en la preparacion de un medicamento para tratar glaucoma

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP980101150A AR011192A1 (es) 1997-03-17 1998-03-13 Composiciones oftalmicas que comprenden una prostaglandina y el uso de los mismos en la preparacion de un medicamento para tratar glaucoma

Country Status (32)

Country Link
EP (1) EP0969846B2 (https=)
JP (2) JP4920124B2 (https=)
KR (1) KR100555818B1 (https=)
CN (1) CN1236775C (https=)
AR (2) AR002194A1 (https=)
AT (1) ATE257385T1 (https=)
AU (1) AU738781B2 (https=)
BR (2) BR9808016A (https=)
CA (1) CA2280089C (https=)
CL (1) CL2009001870A1 (https=)
CO (1) CO4940427A1 (https=)
CY (1) CY2526B1 (https=)
CZ (1) CZ299833B6 (https=)
DE (1) DE69820997T3 (https=)
DK (1) DK0969846T4 (https=)
EE (1) EE04091B1 (https=)
ES (1) ES2214706T5 (https=)
HU (1) HU228896B1 (https=)
ID (1) ID22389A (https=)
IL (1) IL131041A0 (https=)
MY (1) MY122237A (https=)
NO (1) NO327713B1 (https=)
NZ (1) NZ337322A (https=)
PE (1) PE61899A1 (https=)
PL (1) PL197509B1 (https=)
PT (1) PT969846E (https=)
RU (1) RU2197970C2 (https=)
SI (1) SI0969846T2 (https=)
TW (1) TW527187B (https=)
UA (1) UA63938C2 (https=)
WO (1) WO1998041208A1 (https=)
ZA (1) ZA982188B (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
US6187818B1 (en) 1998-06-17 2001-02-13 Pharmacia & Upjohn Company Prostaglandins formulation and process
JP4880808B2 (ja) * 1999-11-15 2012-02-22 久光製薬株式会社 人工涙液型点眼剤組成物
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
CA2422031C (en) * 2000-09-13 2011-11-15 Santen Pharmaceutical Co., Ltd. Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
AU2002218527A1 (en) * 2000-12-05 2002-06-18 Sankyo Company Limited Ocular tension-lowering compositions for topical administration
US20020198209A1 (en) * 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
US7074827B2 (en) 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
RU2266572C1 (ru) * 2004-03-17 2005-12-20 Российский государственный медицинский университет Способ моделирования злокачественной артериальной гипертонии
WO2005089755A1 (en) * 2004-03-18 2005-09-29 R-Tech Ueno, Ltd. Aqueous composition comprising thiazole derivative
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
US7851504B2 (en) * 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
DE202005005094U1 (de) * 2005-03-31 2005-07-28 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Ophthalmische Zusammensetzung
EP1916002B1 (en) * 2005-08-02 2014-03-05 Santen Pharmaceutical Co., Ltd. Method for prevention of degradation of thermally unstable substance
JP5252787B2 (ja) * 2005-08-02 2013-07-31 参天製薬株式会社 熱的に不安定な薬物の分解抑制方法
JP2007099647A (ja) * 2005-09-30 2007-04-19 Kobayashi Pharmaceut Co Ltd 粘膜適用組成物
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
CN101400354B (zh) * 2006-03-13 2014-10-22 株式会社·R-技术上野 水性组合物
KR101454674B1 (ko) * 2006-03-17 2014-10-27 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물
RU2465898C2 (ru) * 2006-10-31 2012-11-10 Алькон Рисерч, Лтд. Модуляторы связывания pai-1 для лечения глазных болезней
WO2008096804A1 (ja) * 2007-02-07 2008-08-14 Teika Pharmaceutical Co., Ltd. ラタノプロスト含有点眼剤
JP2009073788A (ja) * 2007-09-21 2009-04-09 Teika Seiyaku Kk イソプロピルウノプロストン含有眼用組成物
NZ584275A (en) * 2007-10-08 2012-06-29 Fovea Pharmaceuticals Aqueous cyclosporine ophthalmic formulations
ES2638771T3 (es) * 2008-03-17 2017-10-24 Novartis Ag Composiciones farmacéuticas acuosas que contienen complejos de borato-poliol
TWI544927B (zh) * 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
RU2402316C2 (ru) * 2009-01-11 2010-10-27 Пшеничников Виталий Георгиевич Фармацевтическая антиглаукомная композиция
US8952051B2 (en) 2009-11-05 2015-02-10 Allergan, Inc. Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
CN103596572A (zh) * 2011-04-12 2014-02-19 株式会社·R-技术上野 水性眼用组合物
US20130029919A1 (en) * 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery
EP2567689A1 (en) 2011-09-12 2013-03-13 Visiotact Pharma Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
CA2858574C (en) 2011-12-07 2017-05-30 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
NZ732058A (en) 2014-11-25 2023-06-30 Allergan Inc Stabilized omega-3 ophthalmic compositions
AU2019343188A1 (en) * 2018-09-21 2021-05-20 Aufbau Medical Innovations Limited Compositions and methods for glaucoma
AU2020272127B2 (en) 2019-04-12 2022-12-08 Ecolab Usa Inc. Antimicrobial multi-purpose cleaner and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69100171T2 (de) * 1990-05-22 1993-10-28 Ueno Seiyaku Oyo Kenkyujo Kk Synergistische Kombination zur ophthalmischen Verwendung.
WO1992013836A1 (en) * 1991-02-07 1992-08-20 Allergan, Inc. 2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f derivatives
US5767154A (en) * 1991-02-07 1998-06-16 Allergan 5-trans-prostaglandins of the F series and their use as ocular hypotensives
EP0708646A1 (en) * 1994-05-06 1996-05-01 Alcon Laboratories, Inc. Use of vitamin e tocopheryl derivatives in ophthalmic compositions
US5631287A (en) † 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.

Also Published As

Publication number Publication date
CA2280089C (en) 2009-03-03
HUP0002194A2 (hu) 2000-12-28
CN1249687A (zh) 2000-04-05
PE61899A1 (es) 1999-06-30
EP0969846B2 (en) 2010-08-25
DE69820997D1 (de) 2004-02-12
TW527187B (en) 2003-04-11
HK1026841A1 (en) 2000-12-29
JP2010043110A (ja) 2010-02-25
DE69820997T3 (de) 2011-10-06
NZ337322A (en) 2001-05-25
ATE257385T1 (de) 2004-01-15
SI0969846T2 (sl) 2010-12-31
CA2280089A1 (en) 1998-09-24
JP4920124B2 (ja) 2012-04-18
SI0969846T1 (en) 2004-06-30
PL197509B1 (pl) 2008-04-30
DE69820997T2 (de) 2004-12-09
KR20000076330A (ko) 2000-12-26
EE04091B1 (et) 2003-08-15
EP0969846A1 (en) 2000-01-12
UA63938C2 (uk) 2004-02-16
CZ299833B6 (cs) 2008-12-10
AR011192A1 (es) 2000-08-02
CY2526B1 (en) 2006-02-08
NO994481L (no) 1999-09-16
ID22389A (id) 1999-10-07
WO1998041208A1 (en) 1998-09-24
AU738781B2 (en) 2001-09-27
NO994481D0 (no) 1999-09-16
KR100555818B1 (ko) 2006-03-03
ES2214706T3 (es) 2004-09-16
MY122237A (en) 2006-04-29
JP2001515502A (ja) 2001-09-18
DK0969846T4 (da) 2010-12-20
BRPI9816218B1 (pt) 2016-04-12
AU7035398A (en) 1998-10-12
CZ325799A3 (cs) 2000-01-12
HUP0002194A3 (en) 2012-08-28
ES2214706T5 (es) 2011-02-02
PT969846E (pt) 2004-05-31
BR9808016A (pt) 2000-03-08
NO327713B1 (no) 2009-09-14
RU2197970C2 (ru) 2003-02-10
CO4940427A1 (es) 2000-07-24
CN1236775C (zh) 2006-01-18
ZA982188B (en) 1998-09-17
EP0969846B1 (en) 2004-01-07
IL131041A0 (en) 2001-01-28
CL2009001870A1 (es) 2010-01-22
HU228896B1 (en) 2013-06-28
PL335168A1 (en) 2000-04-10
DK0969846T3 (da) 2004-04-13
EE9900410A (et) 2000-04-17

Similar Documents

Publication Publication Date Title
AR002194A1 (es) Instrumento computarizado para el analisis del movimiento.
Proske et al. The proprioceptive senses: their roles in signaling body shape, body position and movement, and muscle force
Enders et al. Measuring human locomotor control using EMG and EEG: Current knowledge, limitations and future considerations
Bao et al. Electrode placement on the forearm for selective stimulation of finger extension/flexion
US20060149119A1 (en) Method for moderation of sleep disorder
Furuya et al. Surmounting the ceiling effect of motor expertise by novel sensory experience with a hand exoskeleton
Wang et al. Effectiveness of soft robotic glove versus repetitive transcranial magnetic stimulation in post-stroke patients with severe upper limb dysfunction: A randomised controlled trial
Zeiss et al. Adapting behavioral treatment for depression to meet the needs of the elderly.
Li et al. Brain–computer interfaces in spinal cord injury: a promising therapeutic strategy
CN102727311A (zh) 一种用于唤醒手术脑功能刺激的装置和设备
Adrian Croonian Lecture.―The messages in sensory nerve fibres and their interpretation
CN1368393A (zh) 仿生波肿瘤治疗仪
Jiang et al. A simple and compact MR-compatible electromagnetic vibrotactile stimulator
KR102562107B1 (ko) 전기 자극을 이용하는 피부 미용기기
CN201453838U (zh) 一种反馈式电子针灸网瘾戒除仪
Hanson et al. Technology for multielectrode microstimulation of brain tissue
Gupta et al. An analysis to generate EMG signal and its perspective: A panoramic approach
CN2031292U (zh) 磁电经络疏导仪
CN2275878Y (zh) 经络全息诊疗仪
CN212118763U (zh) 一种抑郁症治疗装置
Zhang et al. The design and clinical application of sleep disorder treatment system
Schwartz et al. Microcurrent stimulation device controlled by ATMEGA328P-PU chip and Android app
CN2587348Y (zh) 便携式耳穴敏感点定位仪
Kirsch et al. An MRI and MEG Compatible Device for the Study of Somatosensory Information Processing.
CN108113672A (zh) 一种臂环智能训练与评估设备